Protillion Biosciences specializes in the design and development of protein-based drugs.
Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2022 | Series A | $18M | 2 | ARCH Venture Partners Illumina Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | Yes | Series A |
Illumina Ventures | Yes | Series A |